Compare PWR & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PWR | ABT |
|---|---|---|
| Founded | 1997 | 1888 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.2B | 152.9B |
| IPO Year | 1997 | 2006 |
| Metric | PWR | ABT |
|---|---|---|
| Price | $602.55 | $116.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 20 |
| Target Price | ★ $564.40 | $130.90 |
| AVG Volume (30 Days) | 1.2M | ★ 5.8M |
| Earning Date | 04-30-2026 | 04-16-2026 |
| Dividend Yield | 0.07% | ★ 2.76% |
| EPS Growth | ★ 12.77 | N/A |
| EPS | ★ 4.41 | 0.61 |
| Revenue | $28,479,697,000.00 | ★ $44,328,000,000.00 |
| Revenue This Year | $18.56 | $10.75 |
| Revenue Next Year | $12.72 | $8.10 |
| P/E Ratio | ★ $139.86 | $191.25 |
| Revenue Growth | ★ 20.31 | 5.67 |
| 52 Week Low | $363.01 | $81.97 |
| 52 Week High | $788.75 | $137.49 |
| Indicator | PWR | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 75.26 |
| Support Level | $608.78 | $111.18 |
| Resistance Level | $724.24 | $116.82 |
| Average True Range (ATR) | 24.25 | 2.06 |
| MACD | -5.50 | 0.22 |
| Stochastic Oscillator | 17.87 | 89.30 |
Quanta Services is a leading provider of specialty contracting services, delivering comprehensive infrastructure solutions for the electric and gas utility, communications, pipeline, and energy industries in the United States, Canada, and Australia. Quanta reports its results under two segments: electric and underground utility and infrastructure.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.